Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases

Explore clinical trials studying Genital Diseases. Study availability and eligibility vary by location and protocol.

21,658 public trials 3,210 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases trial results

Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366

Conditions
Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
Locations
  • USOR HonorHealth Phoenix, Arizona, United States
  • USOR Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California, San Diego; Moores Cancer Center San Diego, California, United States
View all 66 locations
View Trial Details
Recruiting

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

NCT06915025

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
Locations
  • Advent Health Orlando, Florida, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
  • Washington University School of Medicine in St. Louis St Louis, Missouri, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Recruiting

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

NCT06801236

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
Locations
  • University of California San Diego, Moores Cancer Center La Jolla, California, United States
  • Moffitt Cancer Center, Tampa Tampa, Florida, United States
  • University of Maryland, Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Harvard Medical School-Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

NCT07225270

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations
  • Mt. Sinai Comprehensive Cancer Center Miami, Florida, United States
  • Sarasota Memorial Health Care System Sarasota, Florida, United States
  • Miami Valley Hospital South Centerville, Ohio, United States
  • Zangmeister Cancer Center Columbus, Ohio, United States
View all 16 locations
View Trial Details
Recruiting

Post-Market Study to Assess iTind Safety in Comparison to UroLift

NCT04757116

Conditions
Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Urology Specialists Tucson, Arizona, United States
  • Urology Associates of Central California Fresno, California, United States
  • Golden State Urology Sacramento, California, United States
View all 19 locations
View Trial Details

Related conditions